# Pentosan polysulfate (Elmiron)

Source: https://aminodesk.com/library/pentosan-polysulfate
Publisher: Amino Desk
Updated: 2026-11-17
Clinical review: pending

Pentosan polysulfate is a heparin-like drug, not a peptide. As a capsule it is FDA-approved for one thing, bladder pain from interstitial cystitis. Some clinics sell it as an injection for joints. No injectable form is approved in the US.

- **Legal lane:** the capsule is FDA-approved, prescription only. Injections are not approved.
- **Evidence grade:** A for the approved bladder use. We have not graded the joint injections.
- **Form:** capsule by mouth
- **Brand:** Elmiron

## What it is

Pentosan polysulfate sodium is a semi-synthetic compound related to heparin, with mild blood-thinning effects. How it eases bladder pain is not known. One idea is that it coats the bladder lining. Only about 6% of a dose taken by mouth reaches the bloodstream.

## What the evidence shows

The approval rests on two studies in interstitial cystitis: a three-month placebo-controlled trial of 100 mg three times a day, and a long-term study of 2,499 patients without a comparison group.

For joint pain, the use that puts it on peptide clinic menus, we have not reviewed the trial evidence and do not grade it here. What we can say is that no injectable product has been approved for it in the US.

## Legal status

- FDA-approved as Elmiron capsules for the relief of bladder pain or discomfort associated with interstitial cystitis.
- No injectable pentosan polysulfate is FDA-approved. An injection offered by a clinic is a compounded or imported product.

## Label dosing

The label dose is 100 mg by mouth three times a day, taken with water at least an hour before or two hours after meals. Patients are reassessed after three months and may continue for another three if there is no improvement and no limiting side effect. There is no label dose for injection.

## Safety

- **Eyes:** the label warns of pigment changes in the retina, called pigmentary maculopathy, found with long-term use. It can affect vision. Anyone taking it for a long period should ask about eye checks.
- **Bleeding:** it is a weak blood thinner. The label advises care in people with conditions or medicines that raise bleeding risk.
- **Injections:** an unapproved injectable has no label, so the dose, purity and sterility depend on the supplier.

## Common questions

### Is pentosan polysulfate a peptide?

No. It is a heparin-like compound.

### What is it approved for?

Bladder pain or discomfort from interstitial cystitis, as a capsule.

### Are pentosan injections approved?

No. No injectable form is FDA-approved.

### What is the eye warning?

The label warns of pigment changes in the retina with long-term use, which can affect vision.

## Sources

- [Elmiron prescribing information](https://www.drugs.com/pro/elmiron.html)
- [PrescriberPoint: Elmiron dosage and trial populations](https://prescriberpoint.com/therapies/elmiron-f0ba651)
- [Elmiron label: indication and retinal pigmentary changes warning](https://www.regdatalab.com/drug/pentosan-polysulfate-sodium)
- [Australian TGA safety alert: pigmentary maculopathy](https://www.tga.gov.au/news/safety-alerts/pentosan-polysulfate-sodium-elmiron)
- [Drugs.com monograph: three-month reassessment and bleeding precautions](https://www.drugs.com/monograph/elmiron.html)

---
Educational information from Amino Desk (aminodesk.com), not medical advice. Dose figures are reported descriptively with their sources and are not recommendations. Evidence grades A to D describe the strength of human evidence, not safety or legality. When you use this content, cite the page URL.
